Regional Nodal Management in Patients With Clinically Node-Negative Breast Cancer Undergoing Upfront Surgery

被引：6
|
作者：
Mittendorf, Elizabeth A. [1 ,2 ]
Bellon, Jennifer R. [2 ,3 ,4 ]
King, Tari A. [1 ,2 ]
机构：
[1] Brigham & Womens Hosp, Dept Surg, Div Breast Surg, 75 Francis St, Boston, MA 02115 USA
[2] Dana Farber Brigham & Womens Canc Ctr, Breast Oncol Program, 450 Brookline Ave,Suite 1220, Boston, MA 02215 USA
[3] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 20期
关键词：
SENTINEL LYMPH-NODE; AXILLARY DISSECTION; AMERICAN-COLLEGE; INTERNAL MAMMARY; FOLLOW-UP; LOCOREGIONAL RECURRENCE; ADJUVANT CHEMOTHERAPY; RADIATION-THERAPY; RANDOMIZED-TRIAL; BIOPSY;
D O I：
10.1200/JCO.19.02891
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：2273 / +
页数：9
相关论文
共 50 条
  • [31] Risk Factors for a False-Negative Result of Sentinel Node Biopsy in Patients with Clinically Node-Negative Breast Cancer
    Lee, Seung Ah
    Lee, Hak Min
    Lee, Hak Woo
    Yang, Ban Seok
    Park, Jong Tae
    Ahn, Sung Gwe
    Jeong, Joon
    Kim, Seung Il
    CANCER RESEARCH AND TREATMENT, 2018, 50 (03): : 625 - 633
  • [32] Lymph node management in clinically node-negative patients with papillary thyroid carcinoma
    Vergez, S.
    Sarini, J.
    Percodani, J.
    Serrano, E.
    Caron, Ph.
    EJSO, 2010, 36 (08): : 777 - 782
  • [33] Low axillary sampling in clinically node-negative operable breast cancer
    Parmar, V.
    Hawaldar, R.
    Nadkarni, M. S.
    Badwe, R. A.
    NATIONAL MEDICAL JOURNAL OF INDIA, 2009, 22 (05): : 234 - 236
  • [34] The evolution in management of patients with subcentimeter, node-negative, triple-negative breast cancer
    Wolfe, Emily
    Corsetti, Ralph
    Bolton, John S.
    Stolier, Alan J.
    Fuhrman, George M.
    AMERICAN JOURNAL OF SURGERY, 2013, 206 (06): : 888 - 892
  • [35] Breast cancer: SLN surgery alone is best for node-negative breast cancer
    Hutchinson L.
    Nature Reviews Clinical Oncology, 2010, 7 (12) : 674 - 674
  • [36] Predictive Factors of Nodal Upstaging at Time of Surgery in Clinically Node Negative Patients Undergoing Neoadjuvant Chemotherapy
    Melissa, Rangel
    Alexieva, Julia
    Coogan, Alison
    Marcus, Elizabeth
    Wecsler, Julie
    CANCER RESEARCH, 2024, 84 (09)
  • [37] Nodal staging affects adjuvant treatment choices in elderly patients with clinically node-negative, estrogen receptor-positive breast cancer
    Laws, A.
    Cheifetz, R.
    Warburton, R.
    McGahan, C. E.
    Pao, J. S.
    Kuusk, U.
    Dingee, C.
    Quan, M. L.
    McKevitt, E.
    CURRENT ONCOLOGY, 2020, 27 (05) : 250 - 256
  • [38] Impact on regional recurrence and survival of axillary surgery in women with node-negative primary breast cancer
    Axelsson, C. K.
    Duering, M.
    Christiansen, P. M.
    Wamberg, P. A.
    Soe, K. L.
    Moller, S.
    BRITISH JOURNAL OF SURGERY, 2009, 96 (01) : 40 - 46
  • [39] Neo-adjuvant chemotherapy and axillary de-escalation management for patients with clinically node-negative breast cancer
    Shi, Zhi-qiang
    Qiu, Peng-fei
    Liu, Yan-bing
    Cong, Bin-bin
    Zhao, Tong
    Chen, Peng
    Wang, Chun-jian
    Zhang, Zhao-peng
    Sun, Xiao
    Wang, Yong-sheng
    BREAST JOURNAL, 2019, 25 (06): : 1154 - 1159
  • [40] Selective or routine axillary disease staging for patients with clinically lymph node-negative breast cancer?
    Hieken, Tina J.
    Velasco, Jose M.
    SURGERY, 2006, 140 (04) : 500 - 507
12345